TypeZero Technologies' Artificial Pancreas Solution, inControl AP, Will Be Tested in a Large Scale

 @typezerotech

TypeZero Technologies' Artificial Pancreas Solution, inControl AP, Will Be Tested in a Large Scale, NIH Funded ($12.7 Million) Clinical Study Run by the University of Virginia and 8 Other Locations in 2016

TypeZero's inControl AP platform will revolutionize diabetes management for many Type 1 patients around the world. 

Charlottesville, VA, January 4, 2016 (Newswire.com) -  TypeZero Technologies is pleased to announce that we will provide our inControl AP (Artificial Pancreas) diabetes management platform as the core analytic and control technology for the NIH sponsored, $12.7 million clinical study called the International Diabetes Closed Loop Trial (“IDCL”).  This trial is scheduled to begin in early 2016 and is managed by Dr. Boris Kovatchev and the Center for Diabetes Technology at the University of Virginia (“UVA”).

Click the link to read the whole article.
http://www.newswire.com/news/typezero-technologies-artificial-pancreas-solution-incontrol-ap-will-be-7208527

My question about this amazing technology is will the user be able to customize the range at which this artificial pancreas will maintain a person's blood sugar?   Or is this something you will not be able to adjust at all and what is the lowest a person can set to maintain? 


Please leave me your comments, it helps keep me motivated!